Harbinger Health, a biotechnology company pioneering new technologies to fundamentally change cancer screening and detection, today announced the presentation of three abstracts showcasing multiple ...

"We believe we have a transparent model for the data we handle, rather than the HIPAA model employed by the traditional ...

Lin said he went through two or three iterations of testing nearly 100 potential solutions before he found one that could be ...

No. 23andMe is considered a direct-to-consumer genetic testing company, and transactions with the company are considered commercial, not medical. Because 23andMe is not a medical company, customers' ...

A diagnostic test developed by researchers at the University of California San Francisco aims to help physicians identify causes of severe infections by analyzing DNA and RNA to detect a range of ...

Researchers from the Walter and Eliza Hall Institute (WEHI)in Australia have found a new way to predict a subset of patients ...

Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

That’s the value of having a director who’s a physician and able to communicate that what they’re seeing could have ...